Literature DB >> 3455834

Pseudomonas cepacia colonization and infection in intensive care units.

J M Conly, L Klass, L Larson, J Kennedy, D E Low, G K Harding.   

Abstract

Pseudomonas cepacia has become a prominent epidemic nosocomial pathogen over the past 15 years. Between December 1982 and September 1983 it was isolated from 29 patients in two intensive care units (ICUs) at one hospital. Twelve infections--five bacteremias, four pneumonias and three urinary tract infections--occurred. Most of the isolates (25/29) were from the respiratory tract, and most (23/29) had the same antibiogram as the only environmental isolate, which was cultured from a contaminated ventilator thermometer, a previously unrecognized source of nosocomial infection. The ventilator thermometers were calibrated in a bath whose water had not been changed for months and contained P. cepacia. Despite elimination of this reservoir, P. cepacia was eradicated from the ICUs only after intensive infection control efforts were instituted.

Entities:  

Mesh:

Year:  1986        PMID: 3455834      PMCID: PMC1490838     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  11 in total

1.  Contaminated aqueous benzalkonium chloride. An unnecessary hospital infection hazard.

Authors:  M J Frank; W Schaffner
Journal:  JAMA       Date:  1976-11-22       Impact factor: 56.272

2.  Pseudomonas cepacia (multivorans) septicaemia in an intensive-care unit.

Authors:  I Phillips; S Eykyn; M A Curtis; J J Snell
Journal:  Lancet       Date:  1971-02-20       Impact factor: 79.321

3.  Pseudomonas cepacia in 16 non-fatal cases of postoperative bacteremia derived from intrinsic contamination of the anaesthetic fentanyl. Clinical and epidemiological observations in Denmark and Holland.

Authors:  K Siboni; H Olsen; E Ravn; P Søgaard; A Hjorth; K N Nielsen; K Askgaard; B Secher; J Borghans; L Khing-Ting; H Joosten; W Frederiksen; K Jensen; N Mortensen; O Sebbesen
Journal:  Scand J Infect Dis       Date:  1979

4.  Contamination of commercially packaged urinary catheter kits with the pseudomonad EO-1.

Authors:  P C Hardy; G M Ederer; J M Matsen
Journal:  N Engl J Med       Date:  1970-01-01       Impact factor: 91.245

5.  Colonization and infection with Pseudomonas cepacia.

Authors:  G M Ederer; J M Matsen
Journal:  J Infect Dis       Date:  1972-06       Impact factor: 5.226

6.  Pseudobacteremia caused by povidone-iodine solution contaminated with Pseudomonas cepacia.

Authors:  D E Craven; B Moody; M G Connolly; N R Kollisch; K D Stottmeier; W R McCabe
Journal:  N Engl J Med       Date:  1981-09-10       Impact factor: 91.245

7.  Septicaemia from prolonged intravenous infusions.

Authors:  M L Thong; L K Tay
Journal:  Arch Dis Child       Date:  1975-11       Impact factor: 3.791

8.  Pressure transducers as a source of bacteremia after open heart surgery. Report of an outbreak and guidelines for prevention.

Authors:  R A Weinstein; T G Emori; R L Anderson; W E Stamm
Journal:  Chest       Date:  1976-03       Impact factor: 9.410

9.  Pseudomonas cepacia bacteraemia due to intrinsic contamination of an anaesthetic. Bacteriological and serological observations.

Authors:  J G Borghans; M T Hosli; H Olsen; E M Ravn; K Siboni; P Søgaard
Journal:  Acta Pathol Microbiol Scand B       Date:  1979-02

10.  Pseudomonas cepacia: implications and control of epidemic nosocomial colonization.

Authors:  W J Martone; C A Osterman; K A Fisher; R P Wenzel
Journal:  Rev Infect Dis       Date:  1981 Jul-Aug
View more
  11 in total

1.  Molecular epidemiological investigation using a randomly amplified polymorphic DNA assay of Burkholderia cepacia isolates from nosocomial outbreaks.

Authors:  M Okazaki; T Watanabe; K Morita; Y Higurashi; K Araki; N Shukuya; S Baba; N Watanabe; T Egami; N Furuya; M Kanamori; S Shimazaki; H Uchimura
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

2.  Plasmids of Pseudomonas cepacia strains of diverse origins.

Authors:  E Lennon; B T DeCicco
Journal:  Appl Environ Microbiol       Date:  1991-08       Impact factor: 4.792

Review 3.  The epidemiology of nosocomial epidemic Pseudomonas cepacia infections.

Authors:  W J Martone; O C Tablan; W R Jarvis
Journal:  Eur J Epidemiol       Date:  1987-09       Impact factor: 8.082

4.  Transmissibility and infection control implications of Burkholderia cepacia in cystic fibrosis.

Authors:  S K Fung; H Dick; H Devlin; E Tullis
Journal:  Can J Infect Dis       Date:  1998-05

5.  Burkholderia cepacia respiratory tract acquisition: epidemiology and molecular characterization of a large nosocomial outbreak.

Authors:  C F Pegues; D A Pegues; D S Ford; P L Hibberd; L A Carson; C M Raine; D C Hooper
Journal:  Epidemiol Infect       Date:  1996-06       Impact factor: 2.451

6.  Two novel clinical presentations of Burkholderia cepacia infection.

Authors:  Chiranjoy Mukhopadhyay; Anudita Bhargava; Archana Ayyagari
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

Review 7.  Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.

Authors:  Alex Horsley; Andrew M Jones; Robert Lord
Journal:  Cochrane Database Syst Rev       Date:  2016-01-20

8.  Cepacia Syndrome in a Non-Cystic Fibrosis Patient.

Authors:  Naomi Hauser; Jose Orsini
Journal:  Case Rep Infect Dis       Date:  2015-08-18

9.  Burkholderia contaminans Colonization from Contaminated Liquid Docusate (Colace) in a Immunocompetent Adult with Legionnaire's Disease: Infection Control Implications and the Potential Role of Candida pellucosa.

Authors:  Burke A Cunha; John Gian; Bertamaria Dieguez; Elsa Santos-Cruz; Daniela Matassa; Steve Gerson; Pat Daniels; Carlos Rosales; Rodger P Silletti
Journal:  J Clin Med       Date:  2016-11-30       Impact factor: 4.241

10.  Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.

Authors:  Robert Lord; Andrew M Jones; Alex Horsley
Journal:  Cochrane Database Syst Rev       Date:  2020-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.